Navigation Links
GlaxoSmithKline Consumer Healthcare Helps to Bridge Oral Care Gap in Appalachia
Date:3/9/2009

PITTSBURGH, March 9 /PRNewswire/ -- In Kentucky, nearly one out of every two of the state's children are enrolled in Medicaid, but barely a quarter of the dentists accept the insurance; therefore families on Medicaid are left with few options when it comes to seeing a dentist or receiving dental care.

In an effort to assist, GlaxoSmithKline Consumer Healthcare, manufacturer of Aquafresh(R) and Sensodyne(R), has donated 10,000 toothbrushes and 30,000 tubes of toothpaste. Polident(R), another brand in GSK's oral care portfolio, has also contributed a generous amount of Polident Partials for use in cleaning partial dentures as well as Polident Dentu-Gel Denture Toothpaste.

According to Colin Mackenzie, Vice President of Oral Care at GlaxoSmithKline Consumer Healthcare, "This donation of Aquafresh, Sensodyne, and Polident is one example of how we can support GSK's commitment of providing greater access to quality products and building trust in the community."

Dr. Edwin Smith, D.M.D. and his team at Kids First Dental Care are working to address the serious gap for children's oral care in Kentucky which was brought to the national spotlight during a special entitled "A Hidden America: Children of the Mountains," which aired on ABC's 20'20 last month.

Dr. Smith says he is thrilled by GlaxoSmithKline's donation, "This donation from GSK is one of the most generous we have received. These oral care products will be put to good use because we can actually get them directly into the hands of the children who need them the most."

Kids First Dental Care was formed in 2004 when Dr. Smith collaborated with local school personnel to explore ways to provide dental care to school children. Agreeing that the best way to gain access for children was to take the care directly to them in school, he purchased a used CAT scan trailer and outfitted it with used dental equi
'/>"/>

SOURCE GlaxoSmithKline Consumer Healthcare
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Activplant Corporation Announces Global Agreement with GlaxoSmithKline
2. GlaxoSmithKline and Genmab Submit Arzerra(TM) (Ofatumumab) Application to FDA for the Treatment of Advanced Stage Blood Cancer
3. GlaxoSmithKlines Drug Will Become New Clinical Gold Standard by 2012 for the Treatment of Relapsed/Refractory CLL
4. GlaxoSmithKline Awards Ten Area Healthcare Nonprofits with $40,000 Each in Funding
5. GlaxoSmithKline and Dynavax Announce Worldwide Strategic Alliance : – Developing First-in-Class Endosomal TLR Inhibitors for Autoimmune and Inflammatory Diseases –
6. GlaxoSmithKline Statement on FDA Advisory Committee Vote on Use of Asthma Medicines Containing Long-Acting Beta-Agonists
7. GlaxoSmithKline and The Carter Center Reaffirm Commitment to Global Public Health with Expansion of LF Program
8. GlaxoSmithKline to Acquire the Leading Dry Mouth Brand, Biotene
9. AUDIO from Medialink and GlaxoSmithKline: Give Kids A Boost For Their Health!
10. GlaxoSmithKline Acquires Sirtris Pharmaceuticals, Inc., a World Leader in Sirtuin Research and Development
11. Amira Pharmaceuticals Achieves Milestones in FLAP Inhibitor Program With GlaxoSmithKline
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/22/2014)... HealthDay Reporter TUESDAY, Oct. ... in vitro fertilization (IVF) -- the incubation of embryos in ... device inside the vagina, new research suggests. Scientists from ... an INVOcell, might sharply cut costs for pricey IVF procedures ... accessible to those who don,t live near big-city assisted reproduction ...
(Date:10/22/2014)... Dennis Thompson HealthDay ... U.S. health officials on Monday officially tightened guidelines for health ... no skin exposure and use of a respirator at all ... decided to issue the tougher rules after two Dallas nurses ... in the United States, Liberian national Thomas Eric Duncan. Nina ...
(Date:10/20/2014)... October 20, 2014 The newly updated ... source of thousands of facts, figures and forecasts on ... 68 medical sector forecast categories the Worldwide Medical ... regional and national views on the worldwide medical market ... The report gives you data for 2010-2019, covering each ...
(Date:10/20/2014)... 2014 Allegheny General Hospital’s (AGH) Cardiovascular ... physicians to repair a damaged mitral valve as the ... system, developed by Abbott Vascular , is designed ... life-threatening condition in which the heart’s mitral valve leaflets ... from the heart’s left ventricle into the left atrium. ...
(Date:10/20/2014)... NY (PRWEB) October 20, 2014 ... non-profit organization that helps New Yorkers living with ... changes toward health, housing, recovery and self-sufficiency. Each ... transformed the local community through their tireless efforts. ... Marc Shapses , has been selected as ...
Breaking Medicine News(10 mins):Health News:Experimental Infertility Treatment Seems Effective, Cheaper 2Health News:Experimental Infertility Treatment Seems Effective, Cheaper 3Health News:Experimental Infertility Treatment Seems Effective, Cheaper 4Health News:CDC Tightens Rules on Caring for Ebola Patients 2Health News:CDC Tightens Rules on Caring for Ebola Patients 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 2Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 3Health News:Worldwide Medical Market Forecasts to 2019 a New Research Report Added to ReportsnReports.com 4Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 2Health News:Allegheny General Hospital Introduces New, Beating-Heart Procedure for Mitral Valve Repair 3Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 2Health News:Savills Studley's Marc Shapses To Be Honored as 2014 "Positive Changemaker" by ASCNYC 3
... exposure causes genetic changes in breast cells , , THURSDAY, ... many plastic products used in households caused accelerated breast ... a condition that might predispose the animals to breast ... Butyl benzyl phthalate (BBP) is commonly used to soften ...
... occurrence in television shows and movies, but can watching it make ... Although research has shown ... there has been little direct neuroscientific support for this theory until ... Researchers at Columbia University Medical Centers Functional ...
... Program Sets Stage for Increased Visibility ... Among Shareholders and Investors, ... EMIS ) announced today that it has retained Adam,Friedman Associates, ... is a biopharmaceutical company that focuses on a,unique and improved ...
... Insmed Inc. (Nasdaq:,INSM), a developer of follow-on biologics and ... 5th Annual Global Follow-On Biologics,Conference on December 11, 2007 ... be held at the Hyatt Regency Hotel in Reston,Virginia, ... and will bring together corporate, regulatory, financial, and legal,experts ...
... SAN FRANCISCO, Calif., Dec. 6 Proteolix, Inc.,announced ... studies using,intravenous carfilzomib (PR-171) are to be presented ... Meeting in Atlanta, Georgia, December,8-10, 2007. Carfilzomib is ... for the treatment of multiple myeloma,lymphoma and solid ...
... SGX Pharmaceuticals, Inc.,(Nasdaq: SGXP ) announced today details of ... chronic myelogenous leukemia,(CML) at the upcoming American Society of Hematology,s ... 8th - 11th, 2007 in,Atlanta, Georgia., , The schedule ... Date: ...
Cached Medicine News:Health News:Common Household Chemical Could Raise Breast Cancer Risk 2Health News:Common Household Chemical Could Raise Breast Cancer Risk 3Health News:This is your brain on violent media 2Health News:Emisphere Names Adam Friedman Associates IR Agency of Record 2Health News:Emisphere Names Adam Friedman Associates IR Agency of Record 3Health News:Insmed to Present at the IBC 5th Annual Global Follow-On Biologics Conference 2Health News:Proteolix Announces Clinical Results With Carfilzomib to be Reported at ASH 2007 Annual Meeting 2Health News:SGX Pharmaceuticals BCR-ABL Program to be Presented at the American Society of Hematology 49th Annual Meeting and Exposition 2Health News:SGX Pharmaceuticals BCR-ABL Program to be Presented at the American Society of Hematology 49th Annual Meeting and Exposition 3Health News:SGX Pharmaceuticals BCR-ABL Program to be Presented at the American Society of Hematology 49th Annual Meeting and Exposition 4
(Date:10/22/2014)... Oregon , October 22, 2014 ... "Global Disposable Gloves Market (Product type, Form, End user, ... Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and ... global disposable gloves market. Based on key trends tracked, ... be valued at $7.9 billion by 2020, registering a ...
(Date:10/22/2014)... , Oct. 22, 2014  With a vision ... health medications, a Global Pharmaceutical and Biotech manufacturer ... technology and turnkey solution to protect their animal ... http://photos.prnewswire.com/prnh/20141021/153438 Photo - ... was serialized and aggregated by the Xyntek and ...
(Date:10/22/2014)... , Oct. 21, 2014   BioNano Genomics ... latest genomics research centers to purchase an ... the National Cancer Institute (NCI), NIH Intramural Sequencing ... Before Irys, obtaining a comprehensive view of a ... sequencing (NGS) does not deliver the scalability or ...
Breaking Medicine Technology:Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 2Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 3Global Disposable Gloves Market Expected to Grow to $7.9 Billion by 2020 - Allied Market Research 4Xyntek and Antares Serialization Solution Protects Pets Too! 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 2BioNano's Irys System Adopted by Leading Genomics Centers for Comprehensive Detection of Human Genome Structural Variation 3
... more and are less likely ... to quit, ... Health shows the number of adult smokers in,the state is continuing to drop. ... has gone from 22.4,percent to a new low of 17 percent. Washington continues ...
... Continues to Decline; Strategic Business Unit Realignment, Completed; Clinical Update Provided ... ... Trial, BOCA RATON, Fla., Aug. 1 Nabi,Biopharmaceuticals ... recorded a net loss from continuing,operations of $5.3 million, or $0.09 per ...
Cached Medicine Technology:Adult Smoking Rate Continues Downward Trend 2Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 2Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 3Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 4Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 5Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 6Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 7Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 8Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 9Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 10Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 11Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 12Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results 13
ELISA kit for detection of the cardiac marker Myoglobin. Kit features interchangeable reagents, E-Z Process performed at room temp, and results in less than 1 hour!...
... intended for the quantitative determination of prolactin ... in the diagnosis and treatment of disorders ... BioCheck Prolactin Quantitative Test is based on ... immunosorbent assay. The assay system utilized sheep ...
... assay is an immunometric ('sandwich') ... of Prolactin in human serum ... sample is bound by 2 ... epitopes. One antibody is attached ...
... ELISA Kit is enzyme immunoassay kit ... Prolactin (PRL) concentration in serum. Enzyme ... determination of many protein hormones in ... sensitive, reproducible, rapid and specific assay. ...
Medicine Products: